Phosphoinositide phospholipase C
Phosphoinositide phospholipase C (PLC) is a family of enzymes that are known to cleave phospholipids just before the phosphate group. It plays a significant role in the intracellular signal transduction pathway.
Etymology[edit]
The term "Phosphoinositide phospholipase C" is derived from its function. "Phospho" refers to the presence of a phosphate group, "inositide" refers to the inositol ring structure, and "phospholipase C" refers to the specific type of enzyme that cleaves phospholipids.
Function[edit]
PLC is activated by G protein-coupled receptors and tyrosine kinase-linked receptors. Once activated, it cleaves Phosphatidylinositol 4,5-bisphosphate (PIP2) to form Inositol trisphosphate (IP3) and Diacylglycerol (DAG). IP3 is released into the cytosol where it binds to IP3 receptors, particularly in the endoplasmic reticulum (ER). This binding to the IP3 receptor stimulates the release of calcium ions (Ca2+) from the ER. DAG remains in the plasma membrane and acts as a secondary messenger, activating Protein kinase C (PKC).
Isoforms[edit]
There are thirteen known isoforms of PLC that are divided into six subfamilies depending on their structure and function. These include PLC-β, PLC-γ, PLC-δ, PLC-ε, PLC-ζ, and PLC-η.
Clinical significance[edit]
Mutations in PLC can lead to various diseases such as Usher syndrome, Leukemia, and Autoimmune lymphoproliferative syndrome.
See also[edit]
- Phospholipase
- Phosphatidylinositol 4,5-bisphosphate
- Inositol trisphosphate
- Diacylglycerol
- Protein kinase C
Phosphoinositide_phospholipase_C[edit]
-
Phosphoinositide phospholipase C
-
Crystal structure of phospholipase C
-
PIP2 cleavage to IP3 and DAG
-
Structure of phospholipase C
-
Phosphoinositide phospholipase C
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
